(A,B,C) Serial 10-fold dilutions of haploid strains that were isolated by random mutation screening (green) or that harbor Rad52 mutations created by directed mutagenesis (red). The tested strains are derivative of rad52Δ or rad52Δ srs2Δ null mutants transformed with empty Ycplac111 centromeric plasmid or with wild type or mutated versions of RAD52. (D,E) Survival curves of haploid cells bearing mutations from our collection. Cells were in the log phase of growth when exposed to γ-rays. Data are presented as the mean ± SEM of at least three independent experiments. The rad52-A371T, rad52-S374A and rad52-S387A mutations cannot restore MMS resistance in Srs2-deficient cells, but they can reduce γ-ray sensitivity of Srs2-deficient cells. This difference could be explained by the constant formation of lesions in cells growing in MMS-containing plates, while exposure to γ-rays for a limited period of time creates only a definite number of lesions.